444 related articles for article (PubMed ID: 17761024)
1. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P
Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
[TBL] [Abstract][Full Text] [Related]
2. Arbitrary-primed PCR for genomic fingerprinting and identification of differentially regulated genes in Indian isolates of Leishmania donovani.
Sreenivas G; Singh R; Selvapandiyan A; Negi NS; Nakhasi HL; Salotra P
Exp Parasitol; 2004; 106(3-4):110-8. PubMed ID: 15172218
[TBL] [Abstract][Full Text] [Related]
3. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
4. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
Dey A; Singh S
Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
[TBL] [Abstract][Full Text] [Related]
6. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
Manna M; Majumder HK; Sundar S; Bhaduri AN
Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
[TBL] [Abstract][Full Text] [Related]
7. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.
Sharma P; Gurumurthy S; Duncan R; Nakhasi HL; Salotra P
Parasitol Int; 2010 Jun; 59(2):262-4. PubMed ID: 19963076
[TBL] [Abstract][Full Text] [Related]
10. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar.
Khanra S; Sarraf NR; Das S; Das AK; Roy S; Manna M
Acta Trop; 2016 Dec; 164():177-184. PubMed ID: 27629023
[TBL] [Abstract][Full Text] [Related]
11. RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.
Khanra S; Datta S; Mondal D; Saha P; Bandopadhyay SK; Roy S; Manna M
Acta Trop; 2012 Dec; 124(3):229-34. PubMed ID: 22960646
[TBL] [Abstract][Full Text] [Related]
12. PCR diagnosis of visceral leishmaniasis in an endemic region, Mymensingh district, Bangladesh.
Alam MZ; Shamsuzzaman AK; Kuhls K; Schönian G
Trop Med Int Health; 2009 May; 14(5):499-503. PubMed ID: 19222820
[TBL] [Abstract][Full Text] [Related]
13. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
[TBL] [Abstract][Full Text] [Related]
14. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis.
Salotra P; Duncan RC; Singh R; Subba Raju BV; Sreenivas G; Nakhasi HL
Microbes Infect; 2006 Mar; 8(3):637-44. PubMed ID: 16469521
[TBL] [Abstract][Full Text] [Related]
16. Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: correlation with clinical outcome.
Ansari NA; Sharma P; Salotra P
Clin Immunol; 2007 Mar; 122(3):343-8. PubMed ID: 17218153
[TBL] [Abstract][Full Text] [Related]
17. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent.
Alam MZ; Kuhls K; Schweynoch C; Sundar S; Rijal S; Shamsuzzaman AK; Raju BV; Salotra P; Dujardin JC; Schönian G
Infect Genet Evol; 2009 Jan; 9(1):24-31. PubMed ID: 18957333
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
19. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
[TBL] [Abstract][Full Text] [Related]
20. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]